A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
The resurgence of SARS in the late December of 2019 due to a novel coronavirus, SARS-CoV-2, has shadowed the world with a pandemic. The physiopathology of this virus is very much in semblance with the previously known SARS-CoV and MERS-CoV. However, the unprecedented transmissibility of SARS-CoV-2 h...
Main Authors: | Rinki Minakshi, Arif Tasleem Jan, Safikur Rahman, Jihoe Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2020.575404/full |
Similar Items
-
Impact of Diabetes in Patients Diagnosed With COVID-19
by: Mohamed Abu-Farha, et al.
Published: (2020-12-01) -
New hope for treatment of respiratory involvement following COVID-19 by bromhexine
by: Abdolrazagh Barzegar, et al.
Published: (2021-05-01) -
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
by: Ioannis P. Trougakos, et al.
Published: (2021-01-01) -
Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells
by: Junping Yin, et al.
Published: (2020-12-01) -
Secondary Publication: The Pathophysiology of COVID-19 (Coronavirus Disease 2019) Caused by the Infection of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)
by: Ayako Nakamura-Ishizu, et al.
Published: (2021-07-01)